# Safety and Efficacy of SA09012 in Asthma

> **NCT01740986** · PHASE2 · COMPLETED · sponsor: **SamA Pharmaceutical Co., Ltd** · enrollment: 225 (actual)

## Conditions studied

- Mild to Moderate Bronchial Asthma

## Interventions

- **DRUG:** SA09012 Low dose
- **DRUG:** SA09012 High dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01740986
- **Lead sponsor:** SamA Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2015-07
- **Final completion:** 2015-11
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2015-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01740986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01740986, "Safety and Efficacy of SA09012 in Asthma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01740986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*